Barclays »

Trisalus Life Sciences shares owned by Barclays

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $123k 27k 4.65
2025-06-30 $163k 30k 5.44
2025-03-31 $0 32 0.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Trisalus Life Sciences

Nantahala Capital Management
AWM Investment Company
Vanguard Group
Gilder, Gagnon, Howe & Co
BlackRock
Wealthcare Advisory Partners
Alyeska Investment Group
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group
CI Private Wealth
Squarepoint Ops
CWA Asset Management
Bridgeway Capital Management

View all funds holding Trisalus Life Sciences